Intensity of malaria transmission, antimalarial-drug use and resistance in uganda: What is the relationship between these three factors?

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 96, Issue 3, 2002, Pages 310-317

  Talisuna, A O ^a   Langi, P ^a   Bakyaita, N ^a   Egwang, T ^b   Mutabingwa, T K ^c   Watkins, W ^e   Van Marck, E ^f   D'Alessandro U ^g  

^a MINISTRY OF HEALTH   (Uganda)

^b Med Biotech Laboratories Uganda   (Uganda)

^c National Institute for Medical Research   (South Africa)

^d LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^e KEMRI WELLCOME TRUST RESEARCH PROGRAMME   (Kenya)

^f UNIVERSITY OF ANTWERP   (Belgium)

^g INSTITUTE OF TROPICAL MEDICINE   (Belgium)

Author keywords

Chloroquine; Drug resistance; Drug use; Malaria; Plasmodium falciparum; Sulfadoxine pyrimethamine; Transmission intensity; Uganda

Indexed keywords

ANTIMALARIAL AGENT; CHLOROQUINE; FANSIDAR;

ARTICLE; CHILD; CONTROLLED STUDY; DISEASE TRANSMISSION; DRUG EFFICACY; DRUG USE; EPIDEMIOLOGICAL DATA; EXPOSURE; HEALTH SURVEY; HUMAN; IN VIVO STUDY; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; NONHUMAN; PREVALENCE; STATISTICAL ANALYSIS; TREATMENT FAILURE; UGANDA;

ADOLESCENT; ADULT; ANTIMALARIALS; CHILD; CHILD, PRESCHOOL; CHLOROQUINE; CROSS-SECTIONAL STUDIES; DRUG COMBINATIONS; DRUG RESISTANCE; FEMALE; HUMANS; INFANT; MALARIA, FALCIPARUM; MALE; PREVALENCE; PYRIMETHAMINE; SULFADOXINE; TREATMENT FAILURE; UGANDA;

PLASMODIUM FALCIPARUM; PROTOZOA;

EID: 0036063937     PISSN: 00359203     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0035-9203(02)90108-2     Document Type: Article

References (29)

1. Current views on the population structure of Plasmodium falciparum: Implications for control
2. Random mating in a natural population of the malaria parasite Plasmodium falciparum
3. Beyond chloroquine: Implications of drug resistance for evaluating malaria therapy efficacy and treatment policy in Africa
4. A malariometric survey in Turkana District Kenya: Chemosensitivity of Plasmodium falciparum infections and the identity of the vector
5. Association between antifol resistance in vitro and DHFR gene point mutation in Plasmodium falciparum isolates
6. Use of antimalarial drugs in Mali: Policy versus reality
7. A molecular marker for chloroquine-resistant falciparum malaria
8. Production of monoclonal antibodies against antimalarial drugs for use in immuno assays
9. Simple dipstick tests for the determination of antimalarials in body fluids
10. Modelling a predictable disaster: The rise and spread of drug-resistant malaria
11. Obtaining confidence intervals for the risk ratio in cohort studies
12. Lot quality assurance sampling: Single and double sampling plans
13. Possible sulfadoxine-pyrimethamine resistance in Plasmodium falciparum malaria from Kenya
14. Malaria related anaemia
15. Uses of ecologic analysis in epidemiologic research
16. Efficacy of sulphadoxine-pyrimethamine for acute uncomplicated malaria due to Plasmodium falciparum in Malawian children under five years old
17. Molecular evidence of greater selective pressure for drug resistance exerted by the long-acting antifolate pyrimethamine/sulphadoxine
18. Kenyan Plasmodium falciparum field isolates: Correlation between pyrimethamine and chlorcycloguanil activity in vitro and point mutations in the dihydrofolate reductase domain
19. Mating patterns in malaria parasite populations of Papua New Guinea
20. Pyrimethamine and proguanil resistance-conferring mutations in Plasmodium falciparum dihydrofolate reductase: Polymerase chain reaction methods for surveillance in Africa
21. Mutations in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase and epidemiological patterns of pyrimethamine-sulfadoxine use and resistance
22. Sensitive ELISA dipstick test for the detection of chloroquine in urine under field conditions
23. Using evidence to change antimalarial drug policy in Kenya
24. Relation between severe malaria morbidity in children and level of Plasmodium falciparum transmission in Africa
25. Chloroquine resistance in Plasmodium falciparum from Kenyan infants
26. Malaria pre-eradication programme: 1st, 2nd, 3rd, 4th quarterly reports
27. Anti-malarial drug use among preschool children in an area of seasonal malaria transmission in Kenya
28. Assessment of therapeutic efficacy of antimalarial drugs for uncomplicated malaria in areas with intense transmission
29. Malaria surveys in the Bunyoro, Mubende and Karamoja districts of Uganda